p27Kip1-stathmin interaction influences sarcoma cell migration and invasion

被引:263
作者
Baldassarre, G [1 ]
Belletti, B
Nicoloso, MS
Schiappacassi, M
Vecchione, A
Spessotto, P
Morrione, A
Canzonieri, V
Colombatti, A
机构
[1] IRCCS, Ist Nazl Tumori, Ctr Riferimento Oncol, I-33081 Aviano, Italy
[2] Univ Roma La Sapienza, Osped S Andrea, Div Istopatol, I-00189 Rome, Italy
[3] Jefferson Med Coll, Dept Urol, Philadelphia, PA 19107 USA
[4] Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[5] IRCCS, Ist Nazl Tumori, Ctr Riferimento Oncol, I-33081 Aviano, Italy
[6] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy
[7] Univ Udine, MATI Ctr Excellence, I-33100 Udine, Italy
关键词
D O I
10.1016/j.ccr.2004.11.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidences suggest that cyclin-dependent kinase inhibitors (CKIs) can regulate cellular functions other than cell cycle progression, such as differentiation and migration. Here, we report that cytoplasmic expression of p27(kip1) affects microtubule (MT) stability following cell adhesion on extracellular matrix (ECM) constituents. This p27(kip1) activity is due to its ability to bind and impair the function of the MT-destabilizing protein stathmin. Accordingly, upregulation of p27(kip1) or downregulation of stathmin expression results in the inhibition of mesenchymal cell motility. Moreover, high stathmin and low cytoplasmic p27(kip1) expression correlate with the metastatic phenotype of human sarcomas in vivo. This study provides a functional link between proliferation and invasion of tumor cells based on diverse activities of p27(kip1) in different subcellular compartments.
引用
收藏
页码:51 / 63
页数:13
相关论文
共 54 条
  • [1] Alli E, 2002, CANCER RES, V62, P6864
  • [2] Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells
    Baldassarre, G
    Belletti, B
    Bruni, P
    Boccia, A
    Trapasso, F
    Pentimalli, F
    Barone, MV
    Chiappetta, G
    Vento, MT
    Spiezia, S
    Fusco, A
    Viglietto, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07) : 865 - 874
  • [3] Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
    Baldassarre, G
    Barone, MV
    Belletti, B
    Sandomenico, C
    Bruni, P
    Spiezia, S
    Boccia, A
    Vento, MT
    Romano, A
    Pepe, S
    Fusco, A
    Viglietto, G
    [J]. ONCOGENE, 1999, 18 (46) : 6241 - 6251
  • [4] p27Kip1 modulates cell migration through the regulation of RhoA activation
    Besson, A
    Gurian-West, M
    Schmidt, A
    Hall, A
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 2004, 18 (08) : 862 - 876
  • [5] Putting tumours in context
    Bissell, MJ
    Radisky, D
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 46 - 54
  • [6] p27 as a target for cancer therapeutics
    Blain, SW
    Scher, HI
    Cordon-Cardo, C
    Koff, A
    [J]. CANCER CELL, 2003, 3 (02) : 111 - 115
  • [7] A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression
    Boehm, M
    Yoshimoto, T
    Crook, MF
    Nallamshetty, S
    True, A
    Nabel, GJ
    Nabel, EG
    [J]. EMBO JOURNAL, 2002, 21 (13) : 3390 - 3401
  • [9] Intravital imaging of cell movement in tumours
    Condeelis, J
    Segall, JE
    [J]. NATURE REVIEWS CANCER, 2003, 3 (12) : 921 - 930
  • [10] Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345